Eiger BioPharmaceuticals (STU:72C) OCF Margin %: -406.56% (As of Dec. 2023)


STU:72C Eiger BioPharmaceuticals Inc STU:72C
10 GF Score
Price €6.18
View Full Analysis

What is Eiger BioPharmaceuticals OCF Margin %?

Eiger BioPharmaceuticals STU:72C 10 OCF Margin % is -406.56% as of Dec. 2023. GuruFocus rates STU:72C with a GF Score™ of 10/100.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Eiger BioPharmaceuticals's Cash Flow from Operations for the six months ended in Dec. 2023 was €-26.14 Mil. Eiger BioPharmaceuticals's Revenue for the six months ended in Dec. 2023 was €6.43 Mil. Therefore, Eiger BioPharmaceuticals's OCF Margin % for the quarter that ended in Dec. 2023 was -406.56%.

As of today, Eiger BioPharmaceuticals's current OCF Yield % is 0.00%.

The historical rank and industry rank for Eiger BioPharmaceuticals's OCF Margin % or its related term are showing as below:

STU:72C' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -1170.68

STU:72C's OCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -64.115 vs STU:72C: -1170.68

Eiger BioPharmaceuticals OCF Margin % Related Terms

Eiger BioPharmaceuticals OCF Margin % Historical Data

* Premium members only.

The historical data trend for Eiger BioPharmaceuticals's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eiger BioPharmaceuticals OCF Margin % Chart

Eiger BioPharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -587.55 -615.61 -472.63

Eiger BioPharmaceuticals Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -594.34 -636.98 -525.54 -406.56 0.00

STU:72C vs EDSA, SIGY, EVLO: OCF Margin % Comparison

For the Biotechnology subindustry, Eiger BioPharmaceuticals's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eiger BioPharmaceuticals OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Eiger BioPharmaceuticals's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Eiger BioPharmaceuticals's OCF Margin % falls into.


STU:72C
10GF Score
Eiger BioPharmaceuticals Inc STU:72C
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eiger BioPharmaceuticals OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Eiger BioPharmaceuticals's OCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-68.361/14.464
=-472.63 %

Eiger BioPharmaceuticals's OCF Margin for the quarter that ended in Dec. 2023 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-26.142/6.43
=-406.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -406.56% mean?
Eiger BioPharmaceuticals (STU:72C) has a OCF Margin % of -406.56% as of Dec. 2023. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Eiger BioPharmaceuticals and its competitors.
Is Eiger BioPharmaceuticals' OCF Margin % too high?
Eiger BioPharmaceuticals' current OCF Margin % is -406.56%. Overall, Eiger BioPharmaceuticals has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Eiger BioPharmaceuticals' OCF Margin % compare to EDSA and SIGY?
Eiger BioPharmaceuticals' OCF Margin % of -406.56% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Eiger BioPharmaceuticals and its competitors. Eiger BioPharmaceuticals's current OCF Margin % is -406.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eiger BioPharmaceuticals stock overvalued right now?
Eiger BioPharmaceuticals (STU:72C) has a current OCF Margin % of -406.56%. The current OCF Margin % is -406.56%. Eiger BioPharmaceuticals' overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Eiger BioPharmaceuticals (STU:72C), the current OCF Margin % is -406.56% as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eiger BioPharmaceuticals Business Description

Address 2155 Park Boulevard, Palo Alto, CA, USA, 94306
Eiger BioPharmaceuticals Inc is a commercial stage biopharmaceutical company focused on the development and commercialization of drugs for serious, rare, and ultra-rare diseases with high unmet medical needs and no approved therapies. Its program lonafarnib, a prenylation inhibitor, boosted with ritonavir, for the treatment of Hepatitis Delta Virus (HDV) infection, is in Phase 3 clinical development. Its product candidate pipeline includes Lonafarnib (LNF) in HDV, Peginterferon Lambda (lambda) in HDV, LNF in Progeria, and Progeroid Laminopathies (PL), Avexitide in Post-Bariatric Hypoglycemia (PBH), and Avexitide in Congenital Hyperinsulinism (CHI), all advancing toward Phase 3.
10GF Score

Get the complete analysis for STU:72C

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.18
Price